Three Year Results of Blessed: Expanded Access for DeltaRex-G for an Intermediate Size Population with Advanced Pancreatic Cancer and Sarcoma (NCT04091295) and Individual Patient Use of DeltaRex-G for Solid Malignancies (IND# 19130)
Frontiers in Molecular Medicine（2022）
关键词
DeltaRex-G,cancer gene therapy,CCNG1,cyclin G1 inhibitor,pancreatic cancer,sarcoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要